Jie Shen

机构：Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, The First People's Hospital of Shunde, Peking University Shenzhen Hospital, Second Affiliated Hospital of Zhejiang University · ORCID：0000-0001-6952-9541

发表论文 369 篇 · 总被引 5528 次 · h-index 31

代表论文

• Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 45)
• Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk (2025 · Annals of Medicine · 被引 14)
• Use of technology in prediabetes and precision prevention (2025 · Journal of Diabetes Investigation · 被引 9)
• Peripheral Thyroid Hormone Sensitivity Mediates the Association Between Body Composition and Diabetes in Euthyroid Adults (2025 · Journal of Cachexia Sarcopenia and Muscle · 被引 7)
• High-Throughput Proteomics and Immunohistochemistry of Orbital Connective Tissue in Graves' Orbitopathy (2025 · The Journal of Clinical Endocrinology & Metabolism · 被引 6)
• Designing the next generation of clinical trials in intermediate AMD-a consensus driven, pragmatic, proof of concept early intervention study (2025 · Experimental Eye Research · 被引 5)